Published by Michele Maatouk on 9th September 2025
(Sharecast News) - Swiss pharmaceutical firm Novartis said on Tuesday that it has agreed to buy US clinical-stage biopharmaceutical company Tourmaline Bio for $1.4bn.
URL: http://www.digitallook.com/dl/news/story/35340263/...